Monday, 11 September 2017

Israel's Teva Pharma appoints H Lundbeck's Kare Schultz as CEO

(Reuters) - Teva Pharmaceutical Industries Ltd named H Lundbeck A/S Chief Executive Kare Schultz as its new CEO and president, the Israel-based drugmaker said on Monday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)